Growth Metrics

Insulet (PODD) Operating Expenses (2016 - 2025)

Insulet's Operating Expenses history spans 16 years, with the latest figure at $422.3 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 31.35% year-over-year to $422.3 million; the TTM value through Dec 2025 reached $1.5 billion, up 28.96%, while the annual FY2025 figure was $1.5 billion, 28.97% up from the prior year.
  • Operating Expenses reached $422.3 million in Q4 2025 per PODD's latest filing, up from $392.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $422.3 million in Q4 2025 to a low of $37.5 million in Q3 2021.
  • Average Operating Expenses over 5 years is $223.5 million, with a median of $236.2 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: dropped 3.35% in 2021, then skyrocketed 441.15% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $41.8 million in 2021, then skyrocketed by 363.64% to $193.8 million in 2022, then skyrocketed by 31.42% to $254.7 million in 2023, then rose by 26.23% to $321.5 million in 2024, then skyrocketed by 31.35% to $422.3 million in 2025.
  • Per Business Quant, the three most recent readings for PODD's Operating Expenses are $422.3 million (Q4 2025), $392.4 million (Q3 2025), and $331.1 million (Q2 2025).